Haemonetics Corp.

{
  "main_header": {
    "sid": 1155289,
    "name": "Haemonetics Corp.",
    "stock_name": "Haemonetics Corp.",
    "full_name": "Haemonetics Corp.",
    "name_url": "stocks-analysis/haemonetics-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "68.82",
    "chg": -1.2,
    "chgp": "-1.71%",
    "dir": -1,
    "prev_price": "70.02",
    "mcapval": "3,281.83",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US4050241003",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "540.46 k",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haemonetics-corp-1155289-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haemonetics-corp-valuation-grade-downgraded-from-very-attractive-to-fair-3686188",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HaemoneticsCorp_valuationdot_3686188.png",
        "date": "2025-11-10 15:39:43",
        "description": "Haemonetics Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation, with its stock price at $68.36. Over the past year, the company has faced challenges, posting a -21.00% return, contrasting with the S&P 500's 12.65% gain. Key financial metrics indicate a competitive position despite stock volatility."
      }
    ],
    "total": 11,
    "sid": "1155289",
    "stock_news_url": "https://www.marketsmojo.com/news/haemonetics-corp-1155289"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

2025-11-10 15:39:43

Haemonetics Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation, with its stock price at $68.36. Over the past year, the company has faced challenges, posting a -21.00% return, contrasting with the S&P 500's 12.65% gain. Key financial metrics indicate a competitive position despite stock volatility.

Read full news article

View All News